Acessibilidade / Reportar erro

Attention deficit/hyperactivity disorder and cognitive enhancement: which is the medical responsibility?

The article is about neuropharmacological enhancement of cognition, one of the most common topics of the Neuroethics and Bioethics applied to Neuroscience. It discusses the rational use of these drugs. Social normalization, according to Georges Canguilhem, unifies diversity establishing common values for society. The pharmacological cognitive enhancement can help the compliance of the duties and expectations arising from these values. The cosmetic and therapeutic pharmacological cognitive enhancement (for example, used in ADHD, case in which this article is focusing) implies for the physicians the social responsibility of making easier the compliance of certain social expectations, adhering to them implicitly. Then it is necessary for the physician to reflect about the meaning of those social expectations taking into account values such as life, identity, integrity, freedom, health and welfare of persons and communities.

Cognition; Bioethics; Neuroscience; Social responsability


Conselho Federal de Medicina SGAS 915, lote 72, CEP 70390-150, Tel.: (55 61) 3445-5932, Fax: (55 61) 3346-7384 - Brasília - DF - Brazil
E-mail: bioetica@portalmedico.org.br